Rheumnow Podcast

Dr. Jack Cush reviews the news, journal articles and RNL highlights from this past week on RheumNow.com

This is a replay from the live RNL 2023 meeting and session on SPONDYLOARTHRITIS INNOVATIONS held on March 19, 2023.  This POD (session) devoted to advances in Spondyloarthritis and featured three excellent lectures: - Dr. Atul Deodhar –  Five Advances in SpA - Dr. Denis Poddubnyy - Evaluation of the SI Joint  - Dr. John Reveilee – A Family Hx of AS – what does it mean This Spondyloarthritis Innovations session was sponsored by Lilly

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.  This week we delve into some odd associations, repeat drug warnings and the consequences of antirheumatic therapies.

Audience questions from the live RNL 2023 meeting and the session on EVOLUTION AND ADVANCES IN VASCULITIS held on March 18, 2023. These sessions were sponsore by Sanofi. This POD (session) featured three excellent lectures: - Dr. Robert Spiera: Therapies for GCA and PMR - Dr. Anisha Dua: Assessment of GCA and PMR  - Dr. Carol Langford:  GPA Treatment Choices

This week on the Podcast Dr. Jack Cush reviews the news and journal articles, including the risks of dying, developing RA or autoimmune disease!

Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A: Remission in Psoriatic Arthritis Laura Coates, MBBS University of Oxford JAK inhibitors in Psoriasis and PsA Eric Ruderman, MD Northwestern University Feinberg School of Medicine Pregnancy in PsA Christina Chambers, PhD, MPH

This week on RheumNow.com featuring Dr. Jack Cush

Join us for session highlights from RheumNow Live 2023.  This webinar will feature highlights from these lectures followed by live audience Q & A: Preclinical RA – To Treat or Not To Treat Kevin Deane, MD University of Colorado Year of the JAKi Stanley Cohen, MD, University of Texas Southwestern Medical School Fibroblast/Stromal Cells Michael Brenner, MD Brigham and Women’s Hospital Harvard Medical School

Tune in as rheumatologists Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how you can help mitigate cardiovascular risk in your patients with rheumatoid arthritis. Listen as they share their perspectives on the rheumatologist’s role in cardiovascular risk assessment, patient education, and maintaining a primary focus on patient disease control.

This podcast presented by Dr. Michelle Petri, Professor of Medicine at the Hopkins Lupus Center, describes how estimated glomerular filtration rate slope may be a valid surrogate endpoint for monitoring renal damage accrual in lupus nephritis. 1 1. Levey AS et al. Am J Kidney Dis. 2020;75(1):84–104.